EcoDrugPlus

High Mobility Group Protein B1-Like

Ensembl ID : ENSPNYG00000011980
Gene Symbol: LOC102211219
3 Cross references
509 Possible Orthologues:

High Mobility Group Protein B1-Like

Ensembl ID : ENSPNYG00000014250
Gene Symbol: LOC102206353
2 Cross references
511 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSPNYG00000019210
Gene Symbol: HRH1
2 Cross references
186 Possible Orthologues:

Histamine Receptor H2

Ensembl ID : ENSPNYG00000019278
Gene Symbol: HRH2
3 Cross references
182 Possible Orthologues:

Histamine Receptor H2a

Ensembl ID : ENSPNYG00000017829
Gene Symbol: HRH2A
1 Cross references
189 Possible Orthologues:

Histone Deacetylase 10

Ensembl ID : ENSPNYG00000006594
Gene Symbol: HDAC10
3 Cross references
181 Possible Orthologues:

Histone Deacetylase 11

Ensembl ID : ENSPNYG00000006533
Gene Symbol: HDAC11
3 Cross references
202 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSPNYG00000011472
Gene Symbol: HDAC2
2 Cross references
209 Possible Orthologues:

Histone Deacetylase 3

Ensembl ID : ENSPNYG00000000039
Gene Symbol: HDAC3
4 Cross references
155 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSPNYG00000015221
Gene Symbol: HDAC4
4 Cross references
196 Possible Orthologues:

Histone Deacetylase 4-Like

Ensembl ID : ENSPNYG00000000714
Gene Symbol: LOC102205962
3 Cross references
202 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSPNYG00000016109
Gene Symbol: HDAC5
3 Cross references
194 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).